Key facts
- This page summarizes Peter Siesel's Form 3 filing for IsoPlexis Corp.
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Oct 2021, 16:59.
Peter Siesel - 07 Oct 2021 Form 3 Insider Report for IsoPlexis Corp
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- N/A
- Reported as of
- 07 Oct 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Oct 2021, 16:59:58 UTC
- Next SEC filing
- 04 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shane Sevier, attorney-in-fact for Peter Siesel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter Siesel filed Form 3 for IsoPlexis Corp on 07 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ISO
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,000
- Exercise price
- $1.03
- Footnotes
- F1
ISO
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 52,000
- Exercise price
- $1.03
- Footnotes
- F2
ISO
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $1.83
- Footnotes
- F3
ISO
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 07 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $4.81
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents 28,000 performance-vesting options. Performance-vesting options are subject to vesting based upon the achievement of the 2020 revenue target of IsoPlexis Corporation, which was achieved, and a four-year time-based vesting schedule, with 25% vested on May 18, 2021 and the remainder vesting in 36 equal installments every month thereafter.
Footnote F2
Represents 52,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vested on May 18, 2021 and the remainder vesting in 36 equal installments every month thereafter.
Footnote F3
Represents 20,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vesting on December 15, 2021 and the remainder vesting in 36 equal installments every month thereafter.
Footnote F4
Represents 80,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vesting on June 8, 2022 and the remainder vesting in 36 equal installments every month thereafter.
SEC remarks
Exhibit 24 - Power of Attorney